J Kilian Mellon Selected Research

J Kilian Mellon Research Topics

11	Urinary Bladder Neoplasms (Bladder Cancer) 03/2014 - 02/2002
9	Neoplasms (Cancer) 09/2009 - 02/2002
4	Prostatic Neoplasms (Prostate Cancer) 11/2013 - 11/2002
3	Neoplasm Metastasis (Metastasis) 09/2009 - 02/2002
2	Transitional Cell Carcinoma 01/2010 - 01/2003
2	Breast Neoplasms (Breast Cancer) 03/2002 - 02/2002
1	Carcinoma (Carcinomatosis) 09/2009
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2009
1	Adenocarcinoma 01/2009
1	Carcinogenesis 01/2007
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2005
1	Disease Progression 01/2003

3	Cadherins (E-Cadherin)IBA 01/2013 - 10/2005
3	Proteins (Proteins, Gene)FDA Link 09/2009 - 01/2007
2	Biomarkers (Surrogate Marker)IBA 11/2013 - 01/2009
2	ErbB Receptors (EGF Receptor)IBA 04/2009 - 04/2004
2	S100 Calcium-Binding Protein A4IBA 03/2002 - 02/2002
2	Calcium-Binding ProteinsIBA 03/2002 - 02/2002
1	Cisplatin (Platino)FDA LinkGeneric 03/2014
1	DNA (Deoxyribonucleic Acid)IBA 03/2014
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 03/2014
1	3,3'-diindolylmethane (diindolylmethane)IBA 01/2013
1	Lapatinib (GW572016)FDA Link 04/2009
1	Cytostatic AgentsIBA 04/2009
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2009
1	PolyphenolsIBA 01/2009
1	TeaIBA 01/2009
1	Guanosine Triphosphate (GTP)IBA 01/2009
1	Flutamide (Eulexin)FDA LinkGeneric 03/2008
1	Androgen Receptor AntagonistsIBA 03/2008
1	DNA AdductsIBA 03/2008
1	AndrogensIBA 03/2008
1	Transcription Factors (Transcription Factor)IBA 11/2007
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2005
1	Finasteride (Propecia)FDA LinkGeneric 09/2005
1	Tyrosine Kinase InhibitorsIBA 04/2004
1	Matrix Metalloproteinases (MMPs)IBA 07/2003
1	Tissue Inhibitor of Metalloproteinase-1IBA 07/2003
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 07/2003
1	Radiation-Sensitizing AgentsIBA 06/2003
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2003
1	Heparin (Liquaemin)FDA LinkGeneric 01/2003
1	Epidermal Growth Factor (EGF)IBA 01/2003
1	Androgen Receptors (Androgen Receptor)IBA 11/2002
1	AntioxidantsIBA 11/2002
1	ResveratrolIBA 11/2002
1	Hormones (Hormone)IBA 11/2002
1	CarcinogensIBA 02/2002

3	Chemoprevention 01/2009 - 11/2002
2	Radiotherapy 09/2009 - 06/2003
2	Therapeutics 03/2002 - 02/2002
1	Nephroureterectomy 01/2010
1	Combination Drug Therapy (Combination Chemotherapy) 04/2009
1	Drug Therapy (Chemotherapy) 04/2004
1	Cystectomy 06/2002